Cholesterol Assimilation by Lactobacillus Probiotic Bacteria: An In Vitro Investigation

Article English OPEN
Tomaro-Duchesneau, Catherine; Jones, Mitchell L.; Shah, Divya; Jain, Poonam; Saha, Shyamali; Prakash, Satya;

Excess cholesterol is associated with cardiovascular diseases (CVD), an important cause of mortality worldwide. Current CVD therapeutic measures, lifestyle and dietary interventions, and pharmaceutical agents for regulating cholesterol levels are inadequate. Probiotic b... View more
  • References (39)
    39 references, page 1 of 4

    Anitschkow, N. N.. Uber die veranderung der Kaninchenaorta bei experimenteller cholesterinsteatose. Beiträge zur pathologischen Anatomie und zur allgemeinen Pathologie. 1913; 56: 379-404

    Duff, G. L., McMillan, G. C.. Pathology of atherosclerosis. The American Journal of Medicine. 1951; 11 (1): 92-108

    Tarride, J.-E., Lim, M., DesMeules, M., Luo, W., Burke, N., O'Reilly, D., Bowen, J., Goeree, R.. A review of the cost of cardiovascular disease. Canadian Journal of Cardiology. 2009; 25 (6): e195-e202

    World Health Organization, null. The top 10 causes of death. Fact Sheet. 2011 (310)

    Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., Stone, N. J.. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004; 110 (2): 227-239

    National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), null. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002; 106: 3143-3421

    Pearson, T. A., Laurora, I., Chu, H., Kafonek, S.. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Archives of Internal Medicine. 2000; 160 (4): 459-467

    Brautbar, A., Ballantyne, C. M.. Pharmacological strategies for lowering LDL cholesterol: statins and beyond. Nature Reviews Cardiology. 2011; 8 (5): 253-265

    Foley, K. A., Simpson, R. J., Crouse, J. R., Weiss, T. W., Markson, L. E., Alexander, C. M.. Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events. The American Journal of Cardiology. 2003; 92 (1): 79-81

    Andrews, T. C., Ballantyne, C. M., Hsia, J. A., Kramer, J. H.. Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins. The American Journal of Medicine. 2001; 111 (3): 185-191

  • Similar Research Results (2)
  • Related Organizations (5)
  • Metrics
Share - Bookmark